Header Logo

Connection

GEORGE VAN BUREN to Humans

Back to Details
This is a "connection" page, showing publications GEORGE VAN BUREN has written about Humans.
GEORGE VAN BUREN
Connection Strength
0.310
Humans
  1. A risk-adjusted analysis of drain use in pancreaticoduodenectomy: Some is good, but more may not be better. Surgery. 2022 04; 171(4):1058-1066.
    View in: PubMed
    Score: 0.019
  2. Microbiome changes associated with acute and chronic pancreatitis: A systematic review. Pancreatology. 2021 Jan; 21(1):1-14.
    View in: PubMed
    Score: 0.018
  3. The Landmark Series: Mitigation of the Postoperative Pancreatic Fistula. Ann Surg Oncol. 2021 Feb; 28(2):1052-1059.
    View in: PubMed
    Score: 0.018
  4. Pancreatic Incidentalomas: A Management Algorithm for Identifying Ectopic Spleens. J Surg Res. 2019 04; 236:144-152.
    View in: PubMed
    Score: 0.016
  5. Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection. Nutrients. 2017 Mar 07; 9(3).
    View in: PubMed
    Score: 0.014
  6. Pancreaticoduodenectomy Without Drains: Interpretation of the Evidence. Ann Surg. 2016 May; 263(5):e74-6.
    View in: PubMed
    Score: 0.013
  7. Pancreaticoduodenectomy Without Drains: Interpretation of the Evidence. Ann Surg. 2016 Feb; 263(2):e20-1.
    View in: PubMed
    Score: 0.013
  8. A randomized prospective multicenter trial of pancreaticoduodenectomy with and without routine intraperitoneal drainage. Ann Surg. 2014 Apr; 259(4):605-12.
    View in: PubMed
    Score: 0.012
  9. Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma. Ann Surg Oncol. 2013 Nov; 20(12):3787-93.
    View in: PubMed
    Score: 0.011
  10. Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver. Cancer. 2009 Jul 15; 115(14):3360-8.
    View in: PubMed
    Score: 0.008
  11. Sequential stenotic strictures of the small bowel leading to obstruction. World J Gastroenterol. 2007 Oct 28; 13(40):5391-3.
    View in: PubMed
    Score: 0.007
  12. The development and characterization of a human midgut carcinoid cell line. Clin Cancer Res. 2007 Aug 15; 13(16):4704-12.
    View in: PubMed
    Score: 0.007
  13. The role of nitric oxide in mediating tumour blood flow. Expert Opin Ther Targets. 2006 Oct; 10(5):689-701.
    View in: PubMed
    Score: 0.007
  14. Exploring the role of quality of life in surgical decision making for patients undergoing pancreatectomy. Am J Surg. 2025 Oct; 248:116523.
    View in: PubMed
    Score: 0.006
  15. Tumor Immune Microenvironment Differences Associated With Racial Disparities in Pancreatic Cancer. J Surg Res. 2025 Mar; 307:21-32.
    View in: PubMed
    Score: 0.006
  16. Interobserver Variability and Challenges in Intraoperative Frozen Section Evaluation of Pancreatic Margins in Pancreatectomy Specimens. Ann Clin Lab Sci. 2023 Nov; 53(6):847-860.
    View in: PubMed
    Score: 0.006
  17. CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer. Cancer Res. 2023 04 04; 83(7):1111-1127.
    View in: PubMed
    Score: 0.005
  18. Pretreatment Health-Related Quality-of-Life Status and Survival in Pancreatobiliary Surgical Patients. J Am Coll Surg. 2023 04 01; 236(4):861-870.
    View in: PubMed
    Score: 0.005
  19. Factors associated with inability to return to intended oncologic treatment in pancreatic cancer. Am J Surg. 2022 07; 224(1 Pt B):635-640.
    View in: PubMed
    Score: 0.005
  20. Clinical Translation and Evaluation of a Handheld and Biocompatible Mass Spectrometry Probe for Surgical Use. Clin Chem. 2021 09 01; 67(9):1271-1280.
    View in: PubMed
    Score: 0.005
  21. Rapid diagnosis and tumor margin assessment during pancreatic cancer surgery with the MasSpec Pen technology. Proc Natl Acad Sci U S A. 2021 07 13; 118(28).
    View in: PubMed
    Score: 0.005
  22. Natural killer cells and cytotoxic T lymphocytes are required to clear solid tumor in a patient-derived xenograft. JCI Insight. 2021 07 08; 6(13).
    View in: PubMed
    Score: 0.005
  23. Hemoglobin A1c Is a Predictor of New Insulin Dependence After Partial Pancreatectomy: A Multi-Institutional Analysis. J Gastrointest Surg. 2021 12; 25(12):3119-3129.
    View in: PubMed
    Score: 0.005
  24. Diagnostic Laparoscopy Improves Staging of Malignant Pleural Mesothelioma With Routine Positron Emission Tomography Imaging. Ann Thorac Surg. 2021 11; 112(5):1568-1574.
    View in: PubMed
    Score: 0.005
  25. Long-Term Assessment of Pancreatic Function After Pancreatectomy for Cystic Neoplasms. J Surg Res. 2020 03; 247:547-555.
    View in: PubMed
    Score: 0.004
  26. Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing. Am J Gastroenterol. 2019 09; 114(9):1539-1549.
    View in: PubMed
    Score: 0.004
  27. Mutant p53R175H promotes cancer initiation in the pancreas by stabilizing HSP70. Cancer Lett. 2019 07 01; 453:122-130.
    View in: PubMed
    Score: 0.004
  28. Mesothelin and TGF-a predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib. PLoS One. 2019; 14(3):e0213294.
    View in: PubMed
    Score: 0.004
  29. Evidence Versus Practice in Early Drain Removal After Pancreatectomy. J Surg Res. 2019 04; 236:332-339.
    View in: PubMed
    Score: 0.004
  30. SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma. Cancer Lett. 2019 02 01; 442:310-319.
    View in: PubMed
    Score: 0.004
  31. Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Pancreas. 2018 Nov/Dec; 47(10):1213-1221.
    View in: PubMed
    Score: 0.004
  32. Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. Surgery. 2019 02; 165(2):307-314.
    View in: PubMed
    Score: 0.004
  33. Venous thrombosis following pancreaticoduodenectomy with venous resection. J Surg Res. 2018 08; 228:271-280.
    View in: PubMed
    Score: 0.004
  34. Sequential drain amylase to guide drain removal following pancreatectomy. HPB (Oxford). 2018 06; 20(6):514-520.
    View in: PubMed
    Score: 0.004
  35. Evidence-Based Management of Drains Following Pancreatic Resection: A Systematic Review. Pancreas. 2018 01; 47(1):12-17.
    View in: PubMed
    Score: 0.004
  36. A Prospective Randomized Multicenter Trial of Distal Pancreatectomy With and Without Routine Intraperitoneal Drainage. Ann Surg. 2017 09; 266(3):421-431.
    View in: PubMed
    Score: 0.004
  37. Value of lymph node positivity in treatment planning for early stage pancreatic cancer. Surgery. 2017 09; 162(3):557-567.
    View in: PubMed
    Score: 0.004
  38. Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survival. Oncotarget. 2016 Dec 27; 7(52):87431-87448.
    View in: PubMed
    Score: 0.003
  39. Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation. Cell Rep. 2016 Feb 02; 14(4):907-919.
    View in: PubMed
    Score: 0.003
  40. Pancreatic cancer disparities in African Americans. Pancreas. 2015 May; 44(4):522-7.
    View in: PubMed
    Score: 0.003
  41. The value of drains as a fistula mitigation strategy for pancreatoduodenectomy: something for everyone? Results of a randomized prospective multi-institutional study. J Gastrointest Surg. 2015 Jan; 19(1):21-30; discussion 30-1.
    View in: PubMed
    Score: 0.003
  42. Pancreatic cancer: advances in treatment. World J Gastroenterol. 2014 Jul 28; 20(28):9354-60.
    View in: PubMed
    Score: 0.003
  43. An assessment of the necessity of transfusion during pancreatoduodenectomy. Surgery. 2013 Sep; 154(3):504-11.
    View in: PubMed
    Score: 0.003
  44. Treatment of bacteriobilia decreases wound infection rates after pancreaticoduodenectomy. HPB (Oxford). 2014 Jun; 16(6):592-8.
    View in: PubMed
    Score: 0.003
  45. Hepatocellular carcinoma survival in uninsured and underinsured patients. J Surg Res. 2011 Apr; 166(2):189-93.
    View in: PubMed
    Score: 0.002
  46. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res. 2009 Mar 01; 69(5):1951-7.
    View in: PubMed
    Score: 0.002
  47. Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma. Clin Cancer Res. 2008 Dec 15; 14(24):8052-60.
    View in: PubMed
    Score: 0.002
  48. Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver. Oncogene. 2008 Dec 04; 27(57):7192-200.
    View in: PubMed
    Score: 0.002
  49. Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells. Mol Cancer Ther. 2008 Sep; 7(9):3064-70.
    View in: PubMed
    Score: 0.002
  50. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. J Natl Cancer Inst. 2008 Jan 16; 100(2):109-20.
    View in: PubMed
    Score: 0.002
  51. Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells. Cancer Metastasis Rev. 2007 Dec; 26(3-4):433-41.
    View in: PubMed
    Score: 0.002
  52. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res. 2006 Jul 15; 12(14 Pt 1):4147-53.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.